Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000658110 | SCV000779881 | uncertain significance | not provided | 2018-05-31 | criteria provided, single submitter | clinical testing | The R310H variant in the CP gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The R310H variant is observed in 55/276906 (0.0199%) alleles in large population cohorts, with no homozygotes observed (Lek et al., 2016). The R310H variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. We interpret R310H as a variant of uncertain significance. |
Labcorp Genetics |
RCV001230054 | SCV001402522 | likely benign | Deficiency of ferroxidase | 2024-05-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000658110 | SCV001747382 | uncertain significance | not provided | 2021-06-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001230054 | SCV002788536 | uncertain significance | Deficiency of ferroxidase | 2022-01-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003938008 | SCV004752890 | uncertain significance | CP-related disorder | 2023-11-14 | no assertion criteria provided | clinical testing | The CP c.929G>A variant is predicted to result in the amino acid substitution p.Arg310His. This variant was reported in an individual with Retinal / optic nerve disease, but was classified as uncertain (Table S12, Diñeiro et al 2020. PubMed ID: 32483926). This variant is reported in 0.11% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-148925257-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |